Simultaneous initiation of finerenone and empagliflozin across the spectrum of kidney risk in the CONFIDENCE trial.
- DOI
- 10.1093/ndt/gfaf160
- Published
- 2025 Dec 23
- Container
- Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1093/ndt/gfaf160,
title = {Simultaneous initiation of finerenone and empagliflozin across the spectrum of kidney risk in the CONFIDENCE trial.},
author = {Vaduganathan M and Green JB and Heerspink HJL and Kim SG and Mann JFE and McGill JB and Mottl A and Nangaku M and Rosenstock J and Rossing P and Li L and Li N and Rohwedder K and Scott C and Agarwal R},
year = {2025},
journal = {Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association},
doi = {10.1093/ndt/gfaf160},
url = {https://doi.org/10.1093/ndt/gfaf160}
}RIS
TY - JOUR TI - Simultaneous initiation of finerenone and empagliflozin across the spectrum of kidney risk in the CONFIDENCE trial. AU - Vaduganathan M AU - Green JB AU - Heerspink HJL AU - Kim SG AU - Mann JFE AU - McGill JB AU - Mottl A AU - Nangaku M AU - Rosenstock J AU - Rossing P AU - Li L AU - Li N AU - Rohwedder K AU - Scott C AU - Agarwal R PY - 2025 JO - Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association DO - 10.1093/ndt/gfaf160 UR - https://doi.org/10.1093/ndt/gfaf160 ER -
APA
M, V., JB, G., HJL, H., SG, K., JFE, M., JB, M., A, M., M, N., J, R., P, R., L, L., N, L., K, R., C, S., & R, A. (2025). Simultaneous initiation of finerenone and empagliflozin across the spectrum of kidney risk in the CONFIDENCE trial.. Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association. https://doi.org/10.1093/ndt/gfaf160
Source records
- pubmed · retrieved 2026-09-27T16:32:36.423Z
- europe-pmc · retrieved 2026-09-27T16:32:36.462Z